Back
22nd Century Group Vs. Denali Therapeutics Industry Stock Comparison
Sell
29
XXII
22nd Century Group
Last Price:
$5.73
Seasonality Move:
-4.25%
Sell
41
DNLI
Denali Therapeutics
Last Price:
$23.04
Seasonality Move:
-3.61%
Sell
29
22nd Century Group (XXII)
is a Sell
Is 22nd Century Group a Buy, Sell or Hold?
-
The current 22nd Century Group [XXII] share price is $5.10. The Score for XXII is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
XXII is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy, Sell or Hold?
-
The current Denali Therapeutics [DNLI] share price is $23.04. The Score for DNLI is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
DNLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XXII Stock Price Chart
What is 22nd Century Group's stock price today?
-
The 22nd Century Group share price today is $5.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XXII is experiencing slight buying pressure.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $23.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
XXII Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1 | Sell |
Relative Strength Index (14 RSI): | 41.18 | Sell |
Chaikin Money Flow: | -620478 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.5 | Sell |
Relative Strength Index (14 RSI): | 56.23 | Buy |
Chaikin Money Flow: | 546060 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.02 - 22.5) | Buy |
Bollinger Bands (100): | (22.34 - 28.76) | Sell |
XXII Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.26 | Sell |
20-day SMA: | 5.72 | Sell |
50-day SMA: | 9.61 | Sell |
200-day SMA: | 83.1 | Sell |
8-day EMA: | 6.08 | Sell |
20-day EMA: | 6.57 | Sell |
50-day EMA: | 11.39 | Sell |
200-day EMA: | 801.41 | Sell |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.85 | Buy |
20-day SMA: | 20.86 | Buy |
50-day SMA: | 23.65 | Sell |
200-day SMA: | 23.09 | Sell |
8-day EMA: | 21.38 | Buy |
20-day EMA: | 21.42 | Buy |
50-day EMA: | 22.91 | Buy |
200-day EMA: | 23.56 | Sell |
22nd Century Group Earnings Growth & XXII Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and a decrease next year of $0.00 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.79 per share.
22nd Century Group Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |